UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant … Read more

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer on Wednesday praised the incoming CEO of Walgreens Boots Alliance, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services. “This guy is the real deal. I just salute him … Read more

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer on Squawk on the Street, June 30, 2022. Virginia Sherwood | CNBC CNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing a drug to treat acute pain that is not an opioid. “The biggest … Read more

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer … Read more

;
error: Content is protected !!